City of Hope has announced the addition of pathologist Stanley Hamilton, MD, and researcher Alexey Danilov, MD, PhD, to the National Medical Center in Duarte, California.
Stanley Hamilton, MD
Alexey Danilov, MD, PhD
Michael Caligiuri, MD
Dr. Hamilton is a recognized leader in pathology who helped develop pathology and laboratory medicine into a world-class facility at The University of Texas MD Anderson Cancer Center in Houston. Dr. Hamilton will serve as Chair of the Department of Pathology at City of Hope.
“Pathology is central to achieving success in many of our strategic priorities, including precision medicine, cellular therapy, biomarker discovery, and clinical research,” said Michael Caligiuri, MD, President of City of Hope National Medical Center. “Dr. Hamilton’s strength as a clinician, researcher, and collaborator will be critical as we continue our pursuit to sequence every cancer patient here at a City of Hope in order to best understand and treat their disease.”
Dr. Hamilton hopes to advance and extend the digital transformation now taking place, bringing access to state-of-the-art specialized pathology to every patient at every City of Hope satellite center, improving and enhancing the biomarker data used in clinical trials, and further integrating digital pathology into the overall informatics of the institution.
Dr. Danilov brought his independently funded lab to City of Hope’s Toni Stephenson Lymphoma Center, where he is now Associate Director. Dr. Danilov is an authority in the study and treatment of chronic lymphocytic leukemia and many types of lymphoma.
Dr. Danilov is focused on targeted therapy, identifying cell proteins—some that promote cancer growth, some that inhibit it—learning how they deteriorate, and finding drugs that can affect the process.
The Danilov lab was previously located at the Oregon Health & Science University.
